Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis
Circulation Journal · 2023
DOI: 10.1253/circj.cj-22-0683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Journal, 2023. Verfasst von Yasushi Ichikawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The efficacy of a therapy for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) has not been proven, but tafamidis has been associated with favorable outcomes. However, echocardiographic details of the association of tafamidis with cardiac morphology remain undetermined. Moreover, whether the efficacy of tafamidis varies with the degree of cardiac involvement remains unknown. Using echocardiography, this study investigated the impact of tafamidis on the cardiac morphology of patients with ATTR-CM. METHODS AND RESULTS: Of 52 consecutive patients with biopsy-proven ATTR-CM at Kobe University Hospital, we included 41 for whom details of follow-up echocardiographic examinations after the administration of tafamidis were available. All patients underwent standard and speckle-tracking echocardiography before and a mean (±SD) of 16±8 months after the administration of tafamidis. No significant changes were observed in any representative echocardiographic parameters after the administration of tafamidis. Furthermore, there were no significant changes observed in subgroup analyses (e.g., left ventricular [LV] ejection fraction ≥50% vs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
Zitieren
APA
Ichikawa, Y., Oota, E., Odajima, S., Kintsu, M., Todo, S., Takeuchi, K., Yamauchi, Y., Shiraki, H., Yamashita, K., Fukuda, T., Hisamatsu, E., Hirata, K. I., & Tanaka, H. (2023). Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis. Circulation Journal. https://doi.org/10.1253/circj.cj-22-0683
Vancouver
Ichikawa Y, Oota E, Odajima S, Kintsu M, Todo S, Takeuchi K, et al. Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis. Circulation Journal. 2023. doi:10.1253/circj.cj-22-0683
BibTeX
@article{Ichikawa2023,
author = {Ichikawa, Yasushi and Oota, Eri and Odajima, Susumu and Kintsu, Masayuki and Todo, Saki and Takeuchi, Kimikazu and Yamauchi, Yuki and Shiraki, Hiroaki and Yamashita, Kentaro and Fukuda, Terunobu and Hisamatsu, Eriko and Hirata, Ken-Ichi and Tanaka, Hidekazu},
title = {Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis},
journal = {Circulation Journal},
year = {2023},
doi = {10.1253/circj.cj-22-0683}
}
EUVIMED